Brett King, MD, PhD
Associate Professor of DermatologyCards
About
Research
Academic Achievements & Community Involvement
Clinical Care
Overview
Brett King, MD, PhD, is Associate Professor of Dermatology, specializing in skin diseases recalcitrant to first-line therapies. He has pioneered the use of Janus kinase (JAK) inhibitors in cutaneous diseases, in particular for alopecia areata, vitiligo, atopic dermatitis, granuloma annulare, sarcoidosis, and erosive lichen planus, in addition to other disorders. He sees patients at Yale Dermatology-Middlebury.
Dr. King provides care of patients with all dermatologic conditions, with special interest in:
- atopic dermatitis (eczema)
- alopecia areata
- vitiligo
- sarcoidosis
- granuloma annulare
- lichen planus
- pemphigus vulgaris, bullous pemphigoid, mucous membrane pemphigoid, and other autoimmune blistering diseases
- morphea, systemic sclerosis (scleroderma)
- erythema multiforme
- pruritus (itch)
- drug-induced hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms)
- Stevens-Johnson syndrome, toxic epidermal necrolysis
He is experienced with the use of systemic medications including retinoids, methotrexate, cyclosporine, azathioprine (Imuran®), mycophenolate mofetil (Cellcept®), tofacitinib (Xeljanz®), baricitinib (Olumiant®), upadacitinib (Rinvoq®),ruxolitinib (Jakafi®), apremilast (Otezla®), and the ‘biologics’ (e.g. etanercept (Enbrel®), adalimumab (Humira®), infliximab (Remicade®), ustekinumab (Stelara®), sekucinumab (Cosentyx®), ixekizumab (Taltz®), IVIG, and rituximab (Rituxan®)), as well as phototherapy.
Dr. King is an investigator in numerous clinical trials. He lectures nationally and internationally and publishes extensively.
Dr. King received his B.A. at the University of California at Santa Cruz, his Ph.D. from Stanford University and his M.D. from Yale University School of Medicine. He completed medical internship at Massachusetts General Hospital and dermatology residency at Yale University School of Medicine.
Clinical Specialties
Fact Sheets
Alopecia Areata
Learn More on Yale MedicineVitiligo
Learn More on Yale MedicinePemphigus and Pemphigoid
Learn More on Yale MedicineLichen Planus
Learn More on Yale Medicine
Board Certifications
Dermatology
- Certification Organization
- AB of Dermatology
- Original Certification Date
- 2009
Yale Medicine News
News
News
- June 26, 2023Source: YaleNews
FDA Approves Second Yale-Researched Treatment for Alopecia Areata
- May 17, 2023
Changing the Lives of Patients With Alopecia and Vitiligo
- May 05, 2023
Yale Dermatologists Named Connecticut’s ‘Top Doctors’
- August 18, 2022Source: The New York Times
An Old Medicine Grows New Hair for Pennies a Day, Doctors Say